California Society of Radiologic Technologists (CSRT) Northridge Continuing Education Seminar

Feb 22nd, 2008
Reseda, CA
US
https://csrt.org/seminars.htm
Latest in Home
Spine Osteoporosis Leesle
Opportunistic screening can reveal osteoporotic vertebral fractures
June 23, 2026
Prostate Cancer 400
Blood-based testing could improve prostate cancer screening with MRI
June 22, 2026
Precision Medicine Concept As 2061010022 Marta P Milacroft
Advancing precision medicine through quantitative imaging
June 22, 2026
Examples of DAWM on FLAIR MRI slices. Transversal slices of 1.5T FLAIR MRI scans. For visualization only, brains were skull-stripped and DAWM is shown with dotted lines (occipital DAWM is red, parietal DAWM is orange). Top row images (25% of lobar WM) show larger, more confluent configurations of DAWM, extending beyond the slices shown here.
"Dirty" brain white matter shows no link to dementia in older adults
June 22, 2026
More in Home
Opportunistic screening can reveal osteoporotic vertebral fractures
By Erik L. Ridley
A new study demonstrates the potential of opportunistic screening in improving osteoporosis care.
June 23, 2026
Spine Osteoporosis Leesle
Blood-based testing could improve prostate cancer screening with MRI
By Amerigo Allegretto
Adding the Stockholm3 blood-based biomarker test could help improve prostate cancer screening with MRI.
June 22, 2026
Prostate Cancer 400
Advancing precision medicine through quantitative imaging
By Liz Carey
Coalition develops international QI technical standards across all imaging modalities, envisions credentialed centers.
June 22, 2026
Precision Medicine Concept As 2061010022 Marta P Milacroft
"Dirty" brain white matter shows no link to dementia in older adults
By Kate Madden Yee
The findings could reframe how clinicians and researchers interpret this imaging abnormality.
June 22, 2026
Examples of DAWM on FLAIR MRI slices. Transversal slices of 1.5T FLAIR MRI scans. For visualization only, brains were skull-stripped and DAWM is shown with dotted lines (occipital DAWM is red, parietal DAWM is orange). Top row images (25% of lobar WM) show larger, more confluent configurations of DAWM, extending beyond the slices shown here.
New PET tracer shows promise for guiding pancreatic cancer therapy
By Will Morton
The radiotracer is designed to identify pancreatic tumors eligible for paired therapy with cancer-killing actinium-225 (Ac-225) NMT25.
June 19, 2026
Transaxial Zr-89 NMK89 PET/CT images 1, 24, 72, and 168 hours after injection showing increasing uptake in pancreatic tail adenocarcinoma. Maximum standard uptake value (SUV) in the pancreatic mass is 14 at 168 hours post-injection (crosshairs). PET SUV scale used for windowing was 0 to 10.
SIIM: CVMs on par with LLMs for labeling incidental breast findings
By Amerigo Allegretto
CVMs can accurately label incidental breast abnormalities found on chest CT exams.
June 19, 2026
Img 6956
PET/CT could improve margin assessment for breast tumors
By Amerigo Allegretto
Specimen PET/CT imaging outperforms routine intraoperative margin assessment in breast tumors.
June 19, 2026
Pet Scan Patient 400 (1)
Women's Imaging MinnieCast, Episode 11: Could AI be the future of BI-RADS?
By Amerigo Allegretto
Linda Moy, MD, shares how AI could further improve BI-RADS and predicting breast cancer risk.
June 19, 2026
Minnie Cast Thumbnail (11)
From products to pathways: The new frontier of MedTech innovation
By Phil Rackliffe
In a new column, Phil Rackliffe of GE HealthCare discusses the benefits of a pathway-driven approach to healthcare.
June 19, 2026
Phil Rackliffe
Top World Cup doc in Los Angeles talks radiology
By Will Morton
How is SoFi Stadium managing imaging services during the most-watched single-sport event on the planet?
June 18, 2026
Fifa Ball
Radiology, AI, and the shift from curiosity to accountability
By Rob Carfagno
Radiology executives are beginning to focus on AI performance in practice operations.
June 19, 2026
Rob Carfagno
Single-fraction SBRT a valid option for localized prostate cancer
By Will Morton
Estimated three-year biochemical relapse-free survival was 92.9%.
June 18, 2026
Prostate Imaging
Page 1 of 236
Next Page